Coverage of the 37th Annual Global Congress on Minimally Invasive Gynecology
Karen Abbott, MD and Barbara Nesbitt: "My breast cancer survival story"
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More